Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety, tolerability and possible benefit of letrozole compared to placebo in patients with Hepatopulmonary Syndrome.


Clinical Trial Description

This study is a phase II randomized, double-blind, placebo-controlled parallel trial of 20 subjects with hepatopulmonary syndrome designed to assess the effect of letrozole 2.5 mg orally daily or placebo for 6 months on the alveolar-arterial oxygen gradient (AaPO2). Subjects at each site will be screened at outpatient clinic visit appointments and interested qualified subjects will be consented and offered participation in this trial. Once consent has been obtained baseline values will be established and subjects will begin letrozole with follow-up clinic visits and testing at 3 months, and 6 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04577001
Study type Interventional
Source Mayo Clinic
Contact
Status Terminated
Phase Phase 2
Start date February 18, 2021
Completion date March 26, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT01676597 - Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome N/A
Terminated NCT01518595 - Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis Phase 2
Completed NCT00362752 - A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome Phase 2
Active, not recruiting NCT03092401 - Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study N/A
Not yet recruiting NCT05373134 - Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome N/A
Terminated NCT02021929 - Sorafenib for Hepatopulmonary Syndrome Phase 2
Completed NCT02148536 - Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmonary Syndrome
Terminated NCT00593658 - Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome Phase 1
Recruiting NCT03435406 - Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China N/A
Recruiting NCT04004104 - Supine Exercise in Hepatopulmonary Syndrome Patients With Orthodeoxia N/A